Clinical Trial Update: Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 clinical trial evaluating intranasal PH80 spray for acute management of Premenstrual Dysphoric Disorder, sponsored…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premenstrual Dysphoric Disorder

Drugs mentioned

• PH80 spray

Snippet

Sponsor: Pherin Pharmaceuticals, Inc. | Conditions: Premenstrual Dysphoric Disorder | Phase 3 | Status: UNKNOWN